|
Delayed
Toronto S.E.
17:30:00 27/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0200 CAD | 0.00% |
|
0.00% | -20.00% |
| Market Cap | 1.22M 881K 759K 712K 650K 84.23M 1.23M 8.45M 3.3M 42.52M 3.31M 3.24M 141M | P/E 2024 |
-40.5x | P/E 2025 | -5.33x |
|---|---|---|---|---|---|
| Enterprise Value | 2.22M 1.6M 1.38M 1.29M 1.18M 153M 2.23M 15.34M 5.99M 77.22M 6.01M 5.88M 256M | EV / Sales 2024 |
929,496,174x | EV / Sales 2025 | - |
| Free-Float |
53.08% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | +33.33% | ||
| 1 month | +33.33% | ||
| 3 months | +33.33% | ||
| Current year | -20.00% |
| 1 week | 0.02 | 0.02 | |
| 1 month | 0.02 | 0.02 | |
| Current year | 0.02 | 0.02 | |
| 1 year | 0.02 | 0.04 | |
| 3 years | 0.02 | 0.09 | |
| 5 years | 0.02 | 0.19 | |
| 10 years | 0.01 | 0.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Pirooz
CEO | Chief Executive Officer | 57 | 03/08/2018 |
Raylen Tamayo
DFI | Director of Finance/CFO | - | 04/05/2026 |
Mahmoud Aziz
PSD | President | - | 21/05/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Sina Pirooz
BRD | Director/Board Member | 57 | 03/08/2018 |
Jamie Lewin
BRD | Director/Board Member | 76 | 11/03/2019 |
Kevin Bottomley
BRD | Director/Board Member | 44 | 05/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 09/09/25 | Option | Chairman | 1,000,000 | 1.6885% | ||
| 09/09/25 | Option | Chairman | 1,000,000 | 1.6885% | ||
| 09/09/25 | Option | Chief Executive Officer | 1,000,000 | 1.6885% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -33.33% | -66.67% | 881K | ||
| +3.38% | +3.92% | +26.96% | +78.55% | 48.2B | ||
| +0.66% | +0.45% | +57.74% | +122.48% | 39.97B | ||
| -2.49% | +5.21% | +17.18% | +85.56% | 12.43B | ||
| -1.00% | -2.00% | -11.21% | +12.05% | 12.03B | ||
| +0.19% | 0.00% | +29.35% | +150.00% | 9.35B | ||
| -0.07% | -1.80% | +25.02% | +48.33% | 7.75B | ||
| -1.39% | +3.74% | +28.71% | +223.40% | 7.43B | ||
| -0.26% | +0.10% | +47.89% | -11.58% | 7.22B | ||
| -0.53% | -1.53% | -36.09% | +17.02% | 5.3B | ||
| Average | -0.35% | +2.17% | +15.22% | +65.91% | 14.97B | |
| Weighted average by Cap. | +0.78% | +1.79% | +30.21% | +89.08% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0 0 0 0 0 0.28 0 0.03 0.01 0.14 0.01 0.01 0.47 | - |
| Net income | -73.2K -52.68K -45.4K -42.56K -38.85K -5.04M -73.43K -505K -197K -2.54M -198K -193K -8.43M | -335K -241K -208K -195K -178K -23.05M -336K -2.31M -902K -11.63M -905K -886K -38.58M |
| Net Debt | 804K 579K 499K 468K 427K 55.32M 807K 5.55M 2.16M 27.92M 2.17M 2.13M 92.59M | 999K 719K 620K 581K 530K 68.74M 1M 6.89M 2.69M 34.7M 2.7M 2.64M 115M |
Employees
4,000
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/08/26 | CA$0.0200 | 0.00% | 3,000 |
- Stock Market
- Stocks
- GENX Stock
Select your edition
All financial news and data tailored to specific country editions
















